Gene mutation and loss of protein expression reportedly exist in breast and ovarian cancer and the loss and dysfunction of the BRCA1 protein induced by BRCA1 promoter hypermethylation have been identified in breast and ovarian cancer [44–46]. This evidence concerns the gene BRCA1 and ovarian cancer.